Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.85 USD | -2.86% | +8.28% | -3.64% |
05-09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
05-09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
215M | - | - | - | |||
115B | ||||||
106B | ||||||
21.96B | - | |||||
21.87B | - | |||||
19.21B |
- Stock Market
- Equities
- INMB Stock
- Charts INmune Bio, Inc.
- Sector Chart